臨床眼科60巻4号

2006年04月発行

臨床報告

A型ボツリヌス毒素治療に併用したリドカインテープの効果

著者： 渡部暁也¹ 西起史¹ 西佳代¹

所属機関： ¹西眼科病院

ページ範囲：P.615 - P.619

目的：ボツリヌス毒素の注射時に併用するリドカインテープの疼痛軽減効果の報告。対象と方法：23症例に本治療を行った。片側顔面痙攣の14名については，リドカインテープの併用なしで行った前回の治療と比較した。眼瞼痙攣の8名とMeige症候群1名については，片側にリドカインテープを用い，他側にTegaderm 3M^TMを用いて二重盲検を行った。主観的な痛みを11段階で評価した。結果：顔面痙攣での疼痛は，リドカインテープ使用時で3.00，未使用時で7.94であり，62.2％の軽減効果があった。Meige症候群と眼瞼痙攣では，リドカインテープ使用側で3.78，対照側で8.56であり，55.8％の疼痛軽減効果があった。結論：ボツリヌス毒素の注射時にリドカインテープを併用すると疼痛軽減効果がある。

参考文献

1）Defazio G, Abbruzzese G, Girlanda P et al：Botulinum toxin A treatment for primary hemifacial spasm. A 10-year multicenter study. Arch Neurol59：418-420, 2002

2）Sarifakioglu N, Sarifakioglu E：Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-A injections at different locations：a prospective, single-blinded, randomized controlled trial. Aesthetic Plast Surg Apr 14, 2005［Epub ahead of print］

3）Laborde S, Dover JS, Moore M et al：Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative：a double-blind, randomized controlled trial. J Am Acad Dermatol　48：875-877, 2003

4）Alam M, Dover JS, Arndt KA：Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative：a double-blind, randomized controlled trial. Arch Dermatol　138：510-514, 2002

5）McNelis KA：Intradermal bacteriostatic 0.9％ sodium chloride containing the preservative benzyl alcohol compared with intradermal lidocaine hydrochloride 1％ for attenuation of intravenous cannulation pain. AANA J　66：583-585, 1998

6）Klein AW, Kreyden OP：Storage and dilution of botulinum toxin. In：Kreyden Op et al（eds）：Hyperhidrosis and Botulinum Toxin in Dermatology（Current Problems in Dermatology vol. 30）. 126-130, Karger, Basel, 2002

7）Gassner HG, Sherris DA：Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections：a randomized controlled study. Mayo Clin Proc　75：701-704, 2000

8）Blitzer A, Blinder WJ, Aviv JE et al：The management of hyperfunctional facial lines with botulinum toxin：a collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg123：389-392, 1997

9）Li M, Goldberger BA, Hopkins C：Fatal case of BOTOX-related anaphylaxis? J Forensic Sci　50：169-172, 2005

Cream for botulinum A toxin injection into eyelids. Ophthalmologica　216：355-358, 2002

11）Dutton JJ：Botulinum-A toxin in the treatment of craniocervical muscle spasms：short-and long-term, local and systemic effects. Surv Ophthalmol41：51-65, 1996

12）Gotsis SS, Volnaki OM, Theodossiadis GP：Percutaneous anesthesia with a lignocaineprilocaine cream（EMLA）for eyelid skin surgery. Br J Ophthalmol　78：209-210, 1994

13）Browne J, Raza A, Awad I et al：The effects of EMLA and a topical formulation of 4％ amethocaine（Ametop）on pain associated with retrobulbar injection. Anesthesia　54：596-598, 1999

14）Kuwahara RT, Skinner RB：Emla versus ice as a topical anesthetic. Dermatol Surg　27：495-496, 2001

15）Cerqueiro J, Matti B：Beneficial use of an ice-balloon as part of botulinum toxin type A therapy for facial dynamic wrinkles and other skin injection procedures. Br J Plast Surg　56：619, 2003

16）Baumann L, Frankel S, Welsh E et al：Cryoanalgesia with dischlorotetrafluoroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhidrosis. Dermatol Surg　29：1057-1059, 2003

17）Linder JS, Edmonson BC, Laquis SJ et al：Skin cool-ing before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg　18：441-442, 2002

18）Sarifakioglu N, Sarifakioglu E：Evaluating the effects of ice application on the pain felt during botulinum toxin type-A injections：a prospective, randomized, single-blind controlled trial. Ann Plast Surg　53：543-546, 2004

19）Clarke RS, Hellon RF, Lind AR：The duration of sustained contractions of the human forearm at different muscle temperatures. J Physiol　143：454-473, 1958

20）Onguchi T, Takano Y, Dogru M et al：Lidocaine tape（penles）reduces the pain of botulinum toxin injection for Meige syndrome. Am J Ophthalmol138：654-655, 2004